Levine PH et al. (2022) Individualizing medical treatment in chronic […]
Lloyd A et al. (1990) A double-blind, placebo-controlled trial of
Lloyd A et al. (1993) Immunologic and psychologic therapy for
Abnormalities of carnitine metabolism in chronic fatigue syndrome. Read More »
Majeed T et al. (1995) Abnormalities of carnitine metabolism in
Maltsev D (2022) A comparative study of valaciclovir, valganciclovir, and
McKenzie R et al. (1998) Low-dose hydrocortisone for treatment of
Modafinil: serious skin reactions, hypersensitivity, and psychiatric symptoms. Read More »
Medicines and Healthcare Products Regulatory Agency. (2008) Modafinil: serious skin
4.15 Cardiac rhythm disorders – QT interval prolongation. Read More »
Medicines and Healthcare Products Regulatory Agency . (2015) 4.15 Cardiac
Blacker C et al. (2004) Effect of galantamine hydrobromide in
Blockmans D et al. (2003) Combination therapy with hydrocortisone and
Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome? Read More »
Blockmans D et al. (2006) Does Methylphenidate Reduce the Symptoms
Low-dose naltrexone as a treatment for chronic fatigue syndrome. Read More »
Bolton MJ et al. (2020) Low-dose naltrexone as a treatment
Use of amantadine for chronic fatigue syndrome. Read More »
Bowman MA et al. (1997) Use of amantadine for chronic
Interferon-α therapy for patients with chronic fatigue syndrome [Correspondence]. Read More »
Brook M et al. (1993) Interferon-α therapy for patients with
Bvorobeva OV and Rusaya VV. (2017) Efficacy and safety of
Cabanas H et al. (2019) Naltrexone Restores Impaired Transient Receptor
Cabanas H et al. (2021) Potential Therapeutic Benefit of Low
Cash A and Kaufman DL (2022)Oxaloacetate Treatment For Mental And
